Nova In Silico
PrivateLast Round
Series A
Extension
Feb 16, 2021
Total Funding Raised
$11.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nova In Silico operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Series A Extension round in February 2021.
Nova In Silico is a health-tech company that develops a clinical trial simulation platform, jinkō, which uses AI and mechanistic disease models to predict drug efficacy and optimize clinical trial development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nova In Silico Comparables
Compare Nova In Silico with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantHealth | 88% | |
| InSilicoTrials Technologies | 86% | |
| Unlearn | 81% |
For institutional investors. Book with your work email.
Nova In Silico Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 16, 2021 | ||||
| Grant | Jan 19, 2021 | ||||
| Series A | Jan 9, 2020 |
For institutional investors. Book with your work email.
Nova In Silico Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Grew 16% QoQ, from 56 to 65 employees.
- Jan 27, 2026
Monthly visitors increased 154% from 2K to 5.2K.
For institutional investors. Book with your work email.
Nova In Silico Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nova In Silico's valuation, stock price, and market status.
Is Nova In Silico a public or private company?
Nova In Silico is a private company.
What is the current stock price of Nova In Silico?
Nova In Silico is a private company, so its shares have no public market price. Caplight tracks Nova In Silico's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nova In Silico worth (valuation)?
Valuation information for Nova In Silico is not publicly available.
Can I buy Nova In Silico stock?
Nova In Silico shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nova In Silico's last funding round?
Nova In Silico's most recent funding round was Series A Extension on February 16, 2021.
Who are the main investors in Nova In Silico?
Key investors in Nova In Silico include Bpifrance.
Will Nova In Silico IPO soon?
No public IPO plans have been announced for Nova In Silico.
How can I track Nova In Silico secondary market activity?
Caplight tracks bids, offers, and trades in Nova In Silico's shares on secondary markets.